The “Biobanking Market by Product and Service(Equipment, Consumable, Services, Software), Sample Type (Blood Products, Human Tissues, Cell Lines, Nucleic Acid), Application(Regenerative Medicine, Life Science, Clinical Research) – Global Forecast to 2022” report has been added to Research and Markets’ offering.
The biobanking market is expected to reach USD 2.69 billion by 2022 from USD 1.85 billion in 2017, at a CAGR of 7.8%.
Factors driving the growth of this market include the increasing number of genomics research activities for studying diseases; advances in biobanking and the growing trend of conserving cord blood stem cells of newborns; government & private funding to support regenerative medicine research, and the growing need for cost-effective drug discovery and development. On the other hand, the growth of this market is hindered to some extent due to the high cost of automation and issues related to bio-specimen sample procurement.
The biobanking market is classified by storage type into manual and automated storage. The automated storage type segment is expected to grow at a higher rate during the forecast period. This is attributed to launch of new and advanced automated storage equipment and increasing demand for the quality storage of samples.
The biobanking market is segmented based on applications regenerative medicine, life science research, and clinical research. In 2017, the regenerative medicine segment is expected to command the largest share and is also estimated to grow at the fastest rate as compared to other segments. This can be attributed to increasing research activities in the field of regenerative medicine and rising demand for well-annotated and quality biosamples for research.
Geographically, the biobanking market is dominated by North America, followed by Europe. The Asia-Pacific region is estimated to grow at the fastest rate which can be attributed to the large population in China and India, increasing research in regenerative medicine, and improving life sciences research infrastructure in the region.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Global Biobanking Market, By Product and Service
7 Global Biobanking Market, By Sample Type
8 Global Biobanking Market, By Storage Type
9 Global Biobanking Market, By Application
10 Global Biobanking Market, By Region
11 Competitive Landscape
12 Company Profiles
– Becton Dickinson and Company (U.S.)
– Biobank AS (Norway)
– Biokryo GmbH (Germany)
– Biorep Technologies Inc. (U.S.)
– Brooks Automation (U.S.)
– CSols Ltd (U.K.)
– Cell & Co Bioservices (France)
– Chart Industries (U.S.)
– Greiner Bio One [Greiner Holding AG Austria)]
– Hamilton Company (U.S.)
– LVL Technologies GmbH & Co. KG (Germany)
– LabVantage Solutions Inc. (U.S.).
– Merck KGaA (Germany)
– Micronic (Netherlands)
– Modul-Bio (France)
– Panasonic Healthcare Holdings Co. Ltd (Japan)
– Promega Corporation (U.S.)
– Qiagen N.V. (Germany)
– RUCDR infinite biologics (U.S.)
– TTP Labtech Ltd (U.K.)
– Tecan Group Ltd. (Switzerland)
– Thermo Fisher Scientific Inc. (U.S.)
– VWR Corporation (U.S.)
– Worthington Industries [(Taylor Wharton U.S.)]
– Ziath (U.K.)
For more information about this report visit https://www.researchandmarkets.com/research/t3xfrm/biobanking_market